Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Diane Zisa
Observed name:
D Zisa
Institution:
Boehringer Ingelheim (United States)
Observed institutions:
Hospital for Special Surgery,
Columbia University Irving Medical Center,
Boehringer Ingelheim (United States),
Weill Cornell Medicine
ORCID:
0009-0002-9701-7249
Observed ORCID:
0009-0002-9701-7249
OpenAlex ID:
A5001574089
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series
2020
·
Iris Navarro‐Millán
, Sebastian E. Sattui
, et al.
·
Arthritis & Rheumatology
·
117
PDF
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository
2020
·
Ecem Sevim
, Diane Zisa
, et al.
·
Arthritis Care & Research
·
95
PDF
The Cellular Effect of Lead Poisoning and Its Clinical Picture
2008
·
Robert L. Brochin
, Siena Leone
, et al.
·
71
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial
2026
·
Justin M Oldham
, Arata Azuma
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
18
A Case of Lyme Carditis Presenting with Atrial Fibrillation
2018
·
Peter J. Kennel
, Melvin Parasram
, et al.
·
Case Reports in Cardiology
·
12
PDF
Perioperative Management of Rheumatic Disease and Therapies
2022
·
Diane Zisa
, Susan M. Goodman
·
Rheumatic Disease Clinics of North America
·
11
Perioperative Management of Rheumatic Disease and Therapies
2021
·
Diane Zisa
, Susan M. Goodman
·
Medical Clinics of North America
·
11
Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares
2024
·
Diane Zisa
, Jeffrey Zhang-Sun
, et al.
·
Lupus
·
3
PDF
Late Breaking Abstract - Effect of nerandomilast on clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF): data from final database lock of the FIBRONEER-IPF trial
2025
·
Justin M Oldham
, Arata Azuma
, et al.
·
European Respiratory Journal
·
1
Clinical and Laboratory Characteristics of Persistently Antiphospholipid Antibody Positive Patients: Retrospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (""Registry"")
2018
·
Ecem Sevim
, Diane Zisa
, et al.
·
1
Plain language summary of the results of the FIBRONEER-IPF trial of nerandomilast in patients with idiopathic pulmonary fibrosis
2026
·
Dolly Kervitsky
, Sarah Agnew
, et al.
·
Figshare
Plain language summary of the results of the FIBRONEER-IPF trial of nerandomilast in patients with idiopathic pulmonary fibrosis
2026
·
Dolly Kervitsky
, Sarah Agnew
, et al.
·
Future Rare Diseases
Effect of nerandomilast on clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF): data from final database lock of the FIBRONEER-IPF trial*
2026
·
F Bonella
, J M Oldham
, et al.
·
Pneumologie
Show more works
View as search
Works count:
13
Citation count:
376
H-index:
7
I10-index:
7
Year
Topic
Type